Who
Robert J. Michel
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Daxor; Director, BIO-key International; Chief Financial Officer, Asta Funding.
In numbers
- Trades disclosed
- 98
- Buys
- 18
- Sells
- 4
- Bought
- $131K
- Sold
- $267K
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 12 Mar 2009
- Last trade
- 23 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 25 Jun 2026 | DXR DaxorMedical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | DXR DaxorMedical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 31 Mar 2026filed 31 Mar 2026 | DXR DaxorMedical Devices | SEC FORM 4 Bought | $9,9001,000 at $9.90 | filing |
| 31 Mar 2026filed 31 Mar 2026 | DXR DaxorMedical Devices | SEC FORM 4 Bought | $9,9001,000 at $9.90 | filing |
| 9 Dec 2025filed 11 Dec 2025 | DXR DaxorMedical Devices | SEC FORM 4 Bought | —3,000 at $0.00 | filing |
| 27 May 2025filed 27 May 2025 | BKYI BIO-key InternationalSoftware | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 27 May 2025filed 27 May 2025 | BKYI BIO-key InternationalSoftware | SEC FORM 4 Code A | $1,0001,266 at $0.79 | filing |
| 8 May 2025filed 12 May 2025 | BKYI BIO-key InternationalSoftware | SEC FORM 4 Code A | —3,897 at $0.00 | filing |
| 20 Mar 2025filed 21 Mar 2025 | BKYI BIO-key InternationalSoftware | SEC FORM 4 Code A | —2,971 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | DXR DaxorMedical Devices | SEC FORM 4 Bought | $8,0001,000 at $8.00 | filing |
| 7 Nov 2024filed 8 Nov 2024 | BKYI BIO-key InternationalSoftware | SEC FORM 4 Code A | —2,587 at $0.00 | filing |
| 31 Jul 2024filed 2 Aug 2024 | BKYI BIO-key InternationalSoftware | SEC FORM 4 Code A | —3,500 at $0.00 | filing |
| 31 Jul 2024filed 2 Aug 2024 | BKYI BIO-key InternationalSoftware | SEC FORM 4 Code A | —676 at $0.00 | filing |
| 27 Mar 2024filed 29 Mar 2024 | BKYI BIO-key InternationalSoftware | SEC FORM 4 Code A | —1,429 at $0.00 | filing |
| 27 Mar 2024filed 27 Mar 2024 | DXR DaxorMedical Devices | SEC FORM 4 Bought | $6,525750 at $8.70 | filing |
| 6 Dec 2023filed 6 Dec 2023 | DXR DaxorMedical Devices | SEC FORM 4 Bought | $930120 at $7.75 | filing |
| 1 Dec 2023filed 1 Dec 2023 | DXR DaxorMedical Devices | SEC FORM 4 Bought | $1,395180 at $7.75 | filing |
| 24 Nov 2023filed 27 Nov 2023 | DXR DaxorMedical Devices | SEC FORM 4 Bought | $3,970500 at $7.94 | filing |
| 31 Oct 2023filed 2 Nov 2023 | DXR Daxoroption or derivative · Medical Devices | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 31 Oct 2023filed 2 Nov 2023 | DXR DaxorMedical Devices | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.